Purchase Order 75N93022P00448

Becton, Dickinson and Company, operating through its BD Biosciences division, was awarded a $13,883.23 firm fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) on March 10, 2022, with a completion date of April 30, 2022. The contract covers pre-contract inspection and recertification services for an LSR Fortessa flow cytometry system, a critical research instrument used in biomedical analysis and infectious disease research. The work is to be performed in Bethesda, Maryland, where NIAID maintains its primary research campus. No small business set-aside was applied to this award, reflecting BD's established position as a qualified large contractor in the federal marketplace.

This purchase order represents a routine maintenance and certification action typical of NIAID's management of sophisticated laboratory instrumentation supporting its core research mission in infectious diseases and immunology. BD Biosciences has maintained extensive contracting relationships across multiple National Institutes of Health components, including NIAID, through both individual purchase orders and larger indefinite delivery vehicles, positioning the company as a primary supplier of flow cytometry systems, maintenance services, and related reagents to the federal research enterprise. The LSR Fortessa platform is among BD's flagship flow cytometry offerings, widely deployed across government research facilities for applications ranging from basic immunological research to vaccine development and infectious disease diagnostic work.